Ftse Mib
34.799,27
-0,83%
DAX
20.132,85
-0,44%
S&P 500
5.836,22
0,16%
NASDAQ
19.088,10
-0,38%
Bitcoin
94.810,00
0,32%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ bioAffinity Technologies Inc (BIAF) bioAffinity Technologies Inc (BIAF) Notizie

BIAF

bioAffinity Technologies (BIAF)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:BIAF
DataOraFonteTitoloSimboloCompagnia
13/01/202514:00Business WirebioAffinity Technologies Reports Positive Results from Texas Beta Launch of CyPath® LungNASDAQ:BIAFbioAffinity Technologies Inc
17/12/202414:00Business WireJoin bioAffinity Technologies’ Exclusive Live Investor Webinar and Q&A Session on Thursday, December 19NASDAQ:BIAFbioAffinity Technologies Inc
12/12/202414:00Business WirebioAffinity Technologies Set for Continued Expansion in 2025NASDAQ:BIAFbioAffinity Technologies Inc
05/12/202414:00Business WireVeterans’ Research Foundation Spotlights CyPath® Lung’s Addition to the Federal Supply ScheduleNASDAQ:BIAFbioAffinity Technologies Inc
14/11/202414:00Business WirebioAffinity Technologies Reports $2.4 Million Revenue for Q3 2024NASDAQ:BIAFbioAffinity Technologies Inc
04/11/202414:00Business WirebioAffinity Technologies Appoints New Chief Science Officer to Spearhead Product DevelopmentNASDAQ:BIAFbioAffinity Technologies Inc
30/10/202413:00Business WirebioAffinity Technologies Announces Award of Japanese Patent for CyPath® LungNASDAQ:BIAFbioAffinity Technologies Inc
21/10/202417:39PR Newswire (US)WallachBeth Capital Announces Closing of bioAffinity Technologies $2.6 Million Registered Direct Offering & Concurrent Private PlacementNASDAQ:BIAFbioAffinity Technologies Inc
21/10/202416:45Business WirebioAffinity Technologies Announces Closing of $2.6 Million Registered Direct Offering & Concurrent Private PlacementNASDAQ:BIAFbioAffinity Technologies Inc
18/10/202420:57PR Newswire (US)WallachBeth Capital Announces Pricing of bioAffinity Technologies $2.66 Million Registered Direct Offering & Concurrent Private PlacementNASDAQ:BIAFbioAffinity Technologies Inc
18/10/202418:45Business WirebioAffinity Technologies Announces Pricing of $2.66 Million Registered Direct Offering & Concurrent Private PlacementNASDAQ:BIAFbioAffinity Technologies Inc
16/10/202414:00Business WirebioAffinity’s CyPath® Lung Cancer Test Supported by Newly Published Flow Cytometry GuidelinesNASDAQ:BIAFbioAffinity Technologies Inc
10/10/202414:00Business WirebioAffinity Technologies Names J. Michael Edwards as Chief Financial OfficerNASDAQ:BIAFbioAffinity Technologies Inc
09/10/202414:00Business WirebioAffinity Technologies Awarded U.S. Federal Supply Schedule Contract for CyPath® Lung TestNASDAQ:BIAFbioAffinity Technologies Inc
18/09/202414:00Business WirePeer-Reviewed Study: bioAffinity Technologies’ CyPath® Lung Test Shows Potential Significant Healthcare Savings by Reducing Unnecessary Follow-Up, Medical Complications and OverdiagnosisNASDAQ:BIAFbioAffinity Technologies Inc
26/08/202414:58IH Market NewsIBM Closes China Research Division, Uber Fined $324M, Starliner to Return Without AstronautsNASDAQ:BIAFbioAffinity Technologies Inc
23/08/202423:17Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:BIAFbioAffinity Technologies Inc
23/08/202423:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIAFbioAffinity Technologies Inc
23/08/202423:15Business WirebioAffinity Technologies CFO to Depart for New Opportunity; J. Michael Edwards to Return as Interim CFONASDAQ:BIAFbioAffinity Technologies Inc
14/08/202422:19Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:BIAFbioAffinity Technologies Inc
14/08/202415:37Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BIAFbioAffinity Technologies Inc
14/08/202415:25Business WirebioAffinity Technologies Reports $2.4 Million Revenue for Q2 Driven by Growing CyPath® Lung SalesNASDAQ:BIAFbioAffinity Technologies Inc
12/08/202422:00Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:BIAFbioAffinity Technologies Inc
05/08/202420:00PR Newswire (US)WallachBeth Capital Announces Closing of bioAffinity Technologies Registered Direct Offering and Concurrent Private Placement and Warrant Inducement for Aggregate Gross Proceeds of $1.75 MillionNASDAQ:BIAFbioAffinity Technologies Inc
05/08/202419:17Business WirebioAffinity Technologies Announces Closing of Registered Direct Offering, Concurrent Private Placement and Warrant Inducement for Aggregate Gross Proceeds of $1.75 MillionNASDAQ:BIAFbioAffinity Technologies Inc
05/08/202415:00Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:BIAFbioAffinity Technologies Inc
02/08/202416:00PR Newswire (US)WallachBeth Capital Announces bioAffinity Technologies Pricing of Registered Direct Offering and Concurrent Private Placement and Warrant Inducement for Aggregate Gross Proceeds of $1.75 MillionNASDAQ:BIAFbioAffinity Technologies Inc
02/08/202415:25Business WirebioAffinity Technologies Announces Pricing of Registered Direct Offering and Concurrent Private Placement and Warrant Inducement for Aggregate Gross Proceeds of $1.75 MillionNASDAQ:BIAFbioAffinity Technologies Inc
09/07/202414:00Business WirebioAffinity Technologies Reports 217% Sales Growth in Second Quarter 2024 for CyPath® LungNASDAQ:BIAFbioAffinity Technologies Inc
12/06/202414:00Business WirebioAffinity Technologies Reports Accelerating Growth of Physician Practices Ordering CyPath® Lung TestsNASDAQ:BIAFbioAffinity Technologies Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:BIAF

La tua Cronologia

BIT
ISP
Intesa Sanpaolo
BIT
UCG
Unicredit
BIT
STMMI
ST Microelectronics
BIT
ENEL
Enel
BIT
STLAM
Stellantis NV
BIT
RACE
Ferrari NV
BIT
ENI
Eni
BIT
CPR
Davide Campari
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
BPE
Bper Banca
BIT
IVG
Iveco Group NV
BIT
LDO
Leonardo
BIT
SPM
Saipem
BIT
NEXI
Nexi S.p.A
BIT
PRY
Prysmian
BIT
G
Generali
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network